IP

InMed Pharmaceuticals

INM
NASDAQHealth Care

Income Statement

Total Revenue$4.83M
Gross Profit$1.71M
Operating Income$-7.77M
EBITDA$-6.98M
EBIT$-7.55M
Pre-tax Income$-7.66M
Net Income$-7.91M

Balance Sheet

Cash Equivalent$5.79M
Total Debt$509.14K
Book Value$8.72M
Book Value Per Share16.57

Key Ratios

Return on Equity (ROE)-83.37%
Return on Assets (ROA)-64.92%
Return on Invested Capital (ROI)-83.37%
Net Profit Margin-166.94%
Current Ratio4.41
Quick Ratio3.53
Long-Term Debt / Equitynull